Basilea Pharmaceutica's total assets for Q4 2025 were CHF282.00M, an increase of 13.32% from the previous quarter. CH:BSLN total liabilities were CHF154.06M for the fiscal quarter, a 5.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.